Your search for smoking cessation returned 28 results

The Nicotrol Inhaler (nicotine inhalation system) has been discontinued by Pfizer.

Growing number of cigarette smokers are vaping to help them quit

Study reveals other smoking cessation aids are tied to more successful quits

The placebo-controlled ORCA-2 study evaluated the safety and efficacy of cytisinicline as a treatment for smoking cessation in 810 adult smokers.

Significantly fewer adverse reactions reported by those in the cytisine group versus the varenicline group.

Manufacturers can now adequately supply the market with varenicline at or below the acceptable intake limit of 37ng per day.

N-nitroso-varenicline may be associated with an increased cancer risk based on data from closely related nitrosamine compounds.

However, early electronic cigarette quitters plus stable cigarette use was the most common trajectory in 41.6 percent of participants

To date, the Company has not received any reports of adverse events related to this recall.

This week Pfizer recalled their smoking cessation therapy Chantix. A treatment for acute bacterial skin and skin structure infections becomes available. Aduhelm, the newly approved Alzheimer Disease treatment, has its label updated. A blood lead level test is recalled, and there’s updates to the cancer drug Keytruda.